MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-DL-06-0077409
Unosource Pharma Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹154.2 Cr
▲ 5% YoY
Net profit · FY 2026
₹23.22 Cr
Net margin 15.1%
EBITDA · FY 2026
₹36.41 Cr
EBITDA margin 23.6%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹18.02 Cr
Issued & subscribed
Open charges
₹43 Cr
Satisfied ₹7 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
49
Provident fund records
About Unosource Pharma Limited
Data last updated:
Unosource Pharma Limited is a public limited company based in Delhi, India, a subsidiary of Akums Drugs And Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2013PLC262364. Its GSTIN is 27AABCU6640G1ZB (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹18.02 Cr. It is led by directors including Rajneesh Mehta and Manju Bist.
Its last annual general meeting (AGM) was held on 14 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 305 Third Floor C – Block Plot No. 5 Mohan Place Saraswati Vihar, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹154.2 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹23.22 Cr (net margin 15.1%) and EBITDA of ₹36.41 Cr (EBITDA margin 23.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 14% over five years.
The company has about 49 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Akums and Unosource Pharma. As per MCA filings, the company has open charges of ₹43 Cr and satisfied charges of ₹7 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 1 case is pending. The company has 5 deals on record (5 secondary share transfers); the latest was in June 2022.
Unosource Pharma Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-06-0077409). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unosourcepharma.com.
Company details
CIN U24233DL2013PLC262364
Registration Number 262364
Incorporation Date 18 December 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Parent Company Akums Drugs And Pharmaceuticals Limited
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-DL-06-0077409
Recognitions & Rankings of Unosource Pharma
Contact details
Unosource Pharma Limited's registered office is in Delhi, Delhi. Its website is unosourcepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address305 Third Floor C – Block Plot No. 5 Mohan Place Saraswati Vihar, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Unosource Pharma Limited, buy the company report.
Comprehensive company report
Unosource Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Unosource Pharma operates two associated brands: Akums and Unosource Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| CDMO focusing on spectrum of dosage forms and therapeutic segments | akums.in | |
| Pharmaceutical manufacturing, exporting, and CDMO services. | unosourcepharma.com |
Business activity
The main business activity of Unosource Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Unosource Pharma Limited, buy the company report.
Financials of Unosource Pharma Limited
FY 2026 filings availableUnosource Pharma Limited reported revenue of ₹154.2 Cr (up 5% YoY) for FY 2026.
Revenue · FY 2026
₹154.2 Cr ▲ 5%
Net profit · FY 2026
₹23.22 Cr margin 15.1%
EBITDA · FY 2026
₹36.41 Cr margin 23.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 14%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 47%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 5% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹154.2 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹36.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.6% | ||||
| Net Profit Margin | 15.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unosource Pharma Limited, buy the company report.
Board of directors of Unosource Pharma Limited
Unosource Pharma has 3 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajneesh Mehta Also directs: Akumentis Healthcare Limited | Director | 10 Feb 2026 | 0 Years 9 Months | Current |
| Manju Bist | Director | 20 Aug 2024 | 2 Years 2 Months | Current |
| Suman | Director | 13 May 2026 | 0 Years 6 Months | Current |
Auditor
Unosource Pharma Limited is audited by Walker Chandiok & Co. LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok & Co. LLP | FY 2026 | 001076N/N500013 |
Shareholding
The shareholding of Unosource Pharma Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unosource Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹43 Cr
Satisfied charges
₹7 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Sep 2025 | 101162760 | Hdfc Bank Limited | ₹5 Cr | Open | |
| 11 Sep 2023 | 100777230 | Others | ₹5 Cr | Open | |
| 14 Jul 2023 | 100749854 | The Hongkong and Shanghai Banking Corporation Limited | ₹5 Cr | Open | |
| 16 Dec 2022 | 100663687 | Citi Bank N.A. | ₹28 Cr | Open | |
| 02 Apr 2018 | 100172807 | Yes Bank Limited | ₹5 Cr | Satisfied |
To see the full charge records of Unosource Pharma Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Unosource Pharma Limited has 5 deals on record (5 secondary share transfers); the latest was in June 2022.
Total deals
5
Secondary share transfers
5
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2022 | Secondary share transfer | Undisclosed | Buyer: Akums Drugs and Pharmaceuticals Limited Seller: an individual |
| Jun 2018 | Secondary share transfer | Undisclosed | Buyer: Akums Drugs and Pharmaceuticals Limited Seller: 4 individuals |
| Nov 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Akums Drugs and Pharmaceuticals Limited |
| Apr 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Akums Drugs and Pharmaceuticals Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Unosource Pharma Limited has 5 court cases on record: 3 filed by Unosource Pharma, 2 filed against it. 1 case is pending and 4 are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Pending
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
| NCLT | 2 | 2 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Criminal miscellaneous application | Filed by the company against Aaltop Healthcare Pvt Ltd and 2 Ors ( 48Th Court at Andheri ) | Pending |
| High Court, MAHARASHTRA | Court case (ALP) | Filed by the company against Aaltop Healthcare Pvt. Ltd., and Ors. and 3 others | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against Aaltop Healthcare Private Ltd | Disposed |
| NCLT, New Delhi Bench Court-III | Company petition | Filed against the company by an individual | Disposed |
| NCLT, New Delhi Bench Court-III | Company petition | Filed against the company by an individual | Disposed |
To see the full case history of Unosource Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unosource Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Unosource Pharma Limited has a workforce of 49 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
49
Active EPFO establishments
1
Employee growth
11.4%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 49 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Unosource Pharma Limited, buy the company report.
GST
Unosource Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCU6640G1ZB | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unosource Pharma Limited, buy the company report.
Recent activity
Unosource Pharma Limited has 19 board changes on record since 2014: 3 appointments and 16 cessations. The latest: Suman was appointed as Director on 13 May 2026.
Charges
A charge with Citi Bank N.A. of Rs. 28.00 Cr registered on 16 Dec 2022 with Charge ID 100663687 was modified on 28 Sep 2026.
AGM
Unosource Pharma Limited last Annual general meeting of members was held on 14 Jun 2026 as per latest MCA records.
Appointed
Suman was appointed as Director.
Filing
Unosource Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi Ii.
Appointed
Rajneesh Mehta was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101162760 was registered on 17 Sep 2025.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 5.00 Cr registered on 14 Jul 2023 with Charge ID 100749854 was modified on 22 May 2025.
Ceased
Manju Bist ceased to be Additional Director.
Appointed
Manju Bist was appointed as Director.
Ceased
Rama Shanker ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100777230 was registered on 11 Sep 2023.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 5.00 Cr with Charge ID 100749854 was registered on 14 Jul 2023.
20 earlier events are in the company report.
Frequently asked questions
Unosource Pharma is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 December 2013 (13+ years old) and is registered under CIN U24233DL2013PLC262364.
Unosource Pharma has 3 current directors:
- Rajneesh Mehta - Director
- Manju Bist - Director
- Suman - Director
The latest financial statements of Unosource Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 14 June 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Unosource Pharma is 27AABCU6640G1ZB, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Unosource Pharma is U24233DL2013PLC262364. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unosource Pharma has 5 court cases on record: 3 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.
Unosource Pharma was incorporated on 18 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Unosource Pharma has 5 deals on record (5 secondary share transfers); the latest was in June 2022.
Suman was appointed as Director on 13 May 2026. Rajneesh Mehta was appointed as Director on 10 Feb 2026. Manju Bist ceased to be Additional Director on 17 Feb 2025. Unosource Pharma has 19 board changes on record in total.
Yes, Unosource Pharma is registered as an MSME under Udyam registration (number: UDYAM-DL-06-0077409).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages